CAPR

CAPRICOR THERAPEUTICS INC

CAPR·14070B309·US·Common Stock·Healthcare - Biotechnology-13D/G

CAPR (CAPRICOR THERAPEUTICS INC) is held by 97 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($99.8M), STATE STREET CORP ($81.8M), VANGUARD CAPITAL MANAGEMENT LLC ($55.3M). Net institutional sentiment: Mixed.

97
Holders
(9 Elite)
$586.5M
Total Value
57% (98)
Consensus
56 buying - 42 selling
13F: Insider & Congress: Updated regularly
CAPR

Smart Money Verdict

View all
Loading verdict
Held by 97 funds
9 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jun 24, 2026 · Activists Aug 19, 2026 · Congress none

ActivistMillennium Management LLCMillennium Management LLC4.9%Aug 19, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC7.1%Aug 14, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.9%Aug 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.1M(+21.1%)$99.8M0.0%-45.58%
36
Increased
3.4M(+55.7%)$81.8M0.0%-57.39%
42
Increased
2.3M(+13.3%)$55.3M0.0%-63.48%
33
Increased
1.6M(+73.0%)$38M0.0%-60.75%
44
Unchanged
1.5M$36.3M0.3%-67.68%
0
Increased
1.4M(+22.7%)$33M0.0%-27.25%
35
Increased
1.1M(+47.3%)$27.4M0.0%-65.50%
39
Increased
814,444(+51.0%)$19.6M0.0%-62.45%
39
Increased
684,515(+61.5%)$16.5M0.0%-45.85%
41
Increased
636,087(+67.7%)$15.3M0.0%-62.75%
41
Increased
619,661(+66.6%)$14.9M0.0%-59.07%
41
Increased
503,532(+20.6%)$12.1M0.0%-33.48%
33
Increased
486,836(+63.9%)$11.7M0.0%-65.41%
41
Decreased
402,731(-0.1%)$9.7M0.0%-63.78%
0
Increased
372,539(+16.4%)$9M0.0%-63.43%
32
Increased
362,501(+5.5%)$8.7M0.0%-8.33%
29
Increased
272,609(+114.4%)$6.6M0.0%-62.41%
44
Decreased
251,235(-39.5%)$6M0.0%-62.07%
0
Unchanged
250,000$6M0.1%-67.68%
0
Increased
236,612(+45.2%)$5.7M0.0%-53.01%
37

Showing 1-20 of 109

1 / 6
CAPRCAPRCAPRICOR THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used